Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 607

1.

A mono-carbonyl analog of curcumin induces apoptosis in drug-resistant EGFR-mutant lung cancer through the generation of oxidative stress and mitochondrial dysfunction.

Dai X, Zhang J, Guo G, Cai Y, Cui R, Yin C, Liu W, Vinothkumar R, Zhang T, Liang G, Zhang X.

Cancer Manag Res. 2018 Aug 29;10:3069-3082. doi: 10.2147/CMAR.S159660. eCollection 2018.

2.

Gallic acid and curcumin induce cytotoxicity and apoptosis in human breast cancer cell MDA-MB-231.

Moghtaderi H, Sepehri H, Delphi L, Attari F.

Bioimpacts. 2018;8(3):185-194. doi: 10.15171/bi.2018.21. Epub 2018 Mar 5.

3.

Curcumin mediates polyamine metabolism and sensitizes gastrointestinal cancer cells to antitumor polyamine-targeted therapies.

Murray-Stewart T, Dunworth M, Lui Y, Giardiello FM, Woster PM, Casero RA Jr.

PLoS One. 2018 Aug 23;13(8):e0202677. doi: 10.1371/journal.pone.0202677. eCollection 2018.

4.

Curcumin inhibits proliferation and promotes apoptosis of breast cancer cells.

Hu S, Xu Y, Meng L, Huang L, Sun H.

Exp Ther Med. 2018 Aug;16(2):1266-1272. doi: 10.3892/etm.2018.6345. Epub 2018 Jun 22.

5.

Demethoxycurcumin: A naturally occurring curcumin analogue with antitumor properties.

Hatamipour M, Ramezani M, Tabassi SAS, Johnston TP, Ramezani M, Sahebkar A.

J Cell Physiol. 2018 Aug 4. doi: 10.1002/jcp.27029. [Epub ahead of print] Review.

PMID:
30076727
6.

Functionalized Folic Acid-Conjugated Amphiphilic Alternating Copolymer Actively Targets 3D Multicellular Tumour Spheroids and Delivers the Hydrophobic Drug to the Inner Core.

Li X, Sambi M, DeCarlo A, Burov SV, Akasov R, Markvicheva E, Malardier-Jugroot C, Szewczuk MR.

Nanomaterials (Basel). 2018 Aug 2;8(8). pii: E588. doi: 10.3390/nano8080588.

7.

Curcumin and paclitaxel induce cell death in breast cancer cell lines.

Calaf GM, Ponce-Cusi R, Carrión F.

Oncol Rep. 2018 Oct;40(4):2381-2388. doi: 10.3892/or.2018.6603. Epub 2018 Jul 26.

PMID:
30066930
8.

Orthogonal self-assembly of an organoplatinum(II) metallacycle and cucurbit[8]uril that delivers curcumin to cancer cells.

Datta S, Misra SK, Saha ML, Lahiri N, Louie J, Pan D, Stang PJ.

Proc Natl Acad Sci U S A. 2018 Aug 7;115(32):8087-8092. doi: 10.1073/pnas.1803800115. Epub 2018 Jul 23.

PMID:
30038010
9.

Ancient drug curcumin impedes 26S proteasome activity by direct inhibition of dual-specificity tyrosine-regulated kinase 2.

Banerjee S, Ji C, Mayfield JE, Goel A, Xiao J, Dixon JE, Guo X.

Proc Natl Acad Sci U S A. 2018 Aug 7;115(32):8155-8160. doi: 10.1073/pnas.1806797115. Epub 2018 Jul 9.

10.

Curcumin-Loaded Solid Lipid Nanoparticles Enhanced Anticancer Efficiency in Breast Cancer.

Wang W, Chen T, Xu H, Ren B, Cheng X, Qi R, Liu H, Wang Y, Yan L, Chen S, Yang Q, Chen C.

Molecules. 2018 Jun 29;23(7). pii: E1578. doi: 10.3390/molecules23071578.

11.

Enhanced Intracellular Ca2+ Nanogenerator for Tumor-Specific Synergistic Therapy via Disruption of Mitochondrial Ca2+ Homeostasis and Photothermal Therapy.

Xu L, Tong G, Song Q, Zhu C, Zhang H, Shi J, Zhang Z.

ACS Nano. 2018 Jul 24;12(7):6806-6818. doi: 10.1021/acsnano.8b02034. Epub 2018 Jul 6.

PMID:
29966081
12.

Comparative study of photodynamic activity of methylene blue in the presence of salicylic acid and curcumin phenolic compounds on human breast cancer.

Khorsandi K, Chamani E, Hosseinzadeh G, Hosseinzadeh R.

Lasers Med Sci. 2018 Jun 30. doi: 10.1007/s10103-018-2571-0. [Epub ahead of print]

PMID:
29959633
13.

The Impact of the effectiveness of GATA3 as a prognostic factor in breast cancer.

Fattah FA, Tu SH, Chen LC, Liu YR, Lin YK, Chang HL, Chang HW, Wu CH, Verslues WH, Ho YS.

Hum Pathol. 2018 Jun 11. pii: S0046-8177(18)30210-7. doi: 10.1016/j.humpath.2018.06.004. [Epub ahead of print]

PMID:
29902578
14.

Design, Synthesis, Anticancer Evaluation and Docking Studies of Novel Heterocyclic Derivatives Obtained via Reactions Involving Curcumin.

Borik RM, Fawzy NM, Abu-Bakr SM, Aly MS.

Molecules. 2018 Jun 8;23(6). pii: E1398. doi: 10.3390/molecules23061398.

15.
16.

Theranostic nanoparticles based on magnetic nanoparticles: design, preparation, characterization, and evaluation as novel anticancer drug carrier and MRI contrast agent.

Nosrati H, Salehiabar M, Kheiri Manjili H, Davaran S, Danafar H.

Drug Dev Ind Pharm. 2018 Oct;44(10):1668-1678. doi: 10.1080/03639045.2018.1483398. Epub 2018 Jul 4.

PMID:
29848101
17.

Targeting of PP2Cδ By a Small Molecule C23 Inhibits High Glucose-Induced Breast Cancer Progression In Vivo.

Wu K, Yu X, Huang Z, Zhu D, Yi X, Wu YL, Hao Q, Kemp KT 2nd, Elshimali Y, Iyer R, Nguyen KT, Zheng S, Chen G, Chen QH, Wang G, Vadgama JV, Wu Y.

Antioxid Redox Signal. 2018 Jul 13. doi: 10.1089/ars.2017.7486. [Epub ahead of print]

PMID:
29808718
18.

Oxidative stress in female cancers.

Calaf GM, Urzua U, Termini L, Aguayo F.

Oncotarget. 2018 May 4;9(34):23824-23842. doi: 10.18632/oncotarget.25323. eCollection 2018 May 4. Review.

19.

Targeted therapy of triple negative MDA-MB-468 breast cancer with curcumin delivered by epidermal growth factor-conjugated phospholipid nanoparticles.

Jung KH, Lee JH, Park JW, Kim DH, Moon SH, Cho YS, Lee KH.

Oncol Lett. 2018 Jun;15(6):9093-9100. doi: 10.3892/ol.2018.8471. Epub 2018 Apr 12.

20.

Curcumin for the Prevention of Epithelial-Mesenchymal Transition in Endoxifen-Treated MCF-7 Breast Cancer Cel

Paramita P, Wardhani BW, Wanandi SI, Louisa M.

Asian Pac J Cancer Prev. 2018 May 26;19(5):1243-1249.

Supplemental Content

Loading ...
Support Center